Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A research group at Bonn University and international collaborators discovered a novel receptor, which allows the immune system of modern humans to recognize dangerous invaders, and subsequently elicits an immune response. The blueprint for this advantageous structure was in addition identified in the genome of Neanderthals, hinting at its origin. The receptor provided these early humans with immunity against local diseases. The presence of this receptor in Europeans but its absence in early men suggests that it was inherited from Neanderthals. The results have been published in advance online in the Journal of Biological Chemistry. The printed edition is expected in a following issue.
When pathogens infect the human body, the immune system identifies and attacks dangerous invaders. During evolution, an efficient defence system developed, which vaguely resembles methods used by secret agents. With the help of certain genes, the human leukocyte antigen system (HLA) produces receptors that assess the risk rate of the pathogens using their profile which has just eight amino acids. "This function can be compared to a text which is identified by a spy as being suspicious, based on just a few letters of a word," says Prof. Dr. Norbert Koch from the Institute for Genetics, Department of Immunobiology at the University of Bonn.
Immune System Scans the Amino Acids of the Pathogens
In order to decipher this message, the immune system breaks down the invaders proteins into peptides and subsequently scans a proportion of the peptides for their amino acid sequences. Up until now, a total of three different peptide receptors of more than 1000 different manifestations were known, which in humans can read the telltale letter combinations. "This variety is needed so that the immune system can rate the entire spectrum of pathogens relevant for humans," explains Prof. Koch. A fourth receptor, or another "spy", has now been found by an international team of scientists from the University of Düsseldorf, the Technical University of Munich, Jacobs University Bremen and Cambridge University under the leadership of the immunobiologists at the University of Bonn.
This receptor, which is abbreviated as "HLA-DRaDPb", consists of the combination of subunits of already known receptors. Scientists compared the gene sequence, which encodes the discovered receptor, with data bases and determined that an estimated two-thirds of Europeans carry this important structure. Even Prof. Koch carries the blueprint for this "spy", as one of his students found out by sequencing his DNA. Scientists were nonetheless surprised to learn that the gene sequence required for this receptor is rare in people in southern Africa, the region known as the cradle of mankind. "When early man, the ancestor of today's humans, left Africa and migrated a few hundred thousand years ago to Europe, he did not yet have this receptor," says Prof. Koch.
Modern Man Owes Receptor to Neanderthals
Prof. Dr. Svante Pääbo from the Max Planck Institute for Evolutionary Anthropology in Leipzig played a leading role in 2010 in sequencing and presenting the Neanderthal genome. So, scientists examined whether Neanderthals as an example of early men had the key gene sequence which contains the blueprint for the receptor. Dr. Sebastian Temme, who conducted a major part of the experimental work, compiled, together with colleagues from Düsseldorf, the sequence of the Neanderthal genome, from small fragments obtained from the Neanderthal data base. "The identified Neanderthal gene sequence is almost identical with that of modern humans," concludes Prof. Koch.
Neanderthals probably lived many hundreds of thousands of years in Europe during which time they developed the HLA receptor that provided them with immunity against many pathogens. This means that different to our ancestors from Africa, the Neanderthals which were resident in Europe, carried this receptor on their immune cells. That was a distinct evolutionary advantage," says the immunobiologist from the University of Bonn, who presumes that we modern humans in Europe owe this advantageous receptor to the Neanderthals.
A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species, Journal of Biological Chemistry, DOI: 10.1074/jbc.M113.515767
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Immune System / Vaccines category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Bonn. "'Immune gene' discovered in Neanderthals." Medical News Today. MediLexicon, Intl., 26 Nov. 2013. Web.
8 Mar. 2014. <http://www.medicalnewstoday.com/releases/269270>
University of Bonn. (2013, November 26). "'Immune gene' discovered in Neanderthals." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269270.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.